Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995-2014: a population-based study using linked administrative data.

Walker JD, Slater M, Jones CR, Shah BR, Frymire E, Khan S, Jacklin K, Green ME.

CMAJ. 2020 Feb 10;192(6):E128-E135. doi: 10.1503/cmaj.190836.

PMID:
32041696
2.

Prevalence, incidence and outcomes of diabetes in Ontario First Nations children: a longitudinal population-based cohort study.

Shulman R, Slater M, Khan S, Jones C, Walker JD, Jacklin K, Green ME, Frymire E, Shah BR.

CMAJ Open. 2020 Jan 28;8(1):E48-E55. doi: 10.9778/cmajo.20190226. Print 2020 Jan-Mar.

3.

Peripheral arterial disease in Ontario First Nations people with diabetes: a longitudinal population-based cohort study.

Shah BR, Frymire E, Jacklin K, Jones CR, Khan S, Slater M, Walker JD, Green ME.

CMAJ Open. 2019 Dec 10;7(4):E700-E705. doi: 10.9778/cmajo.20190162. Print 2019 Oct-Dec.

4.

Trends in cardiovascular care and event rates among First Nations and other people with diabetes in Ontario, Canada, 1996-2015.

Chu A, Han L, Roifman I, Lee DS, Green ME, Jacklin K, Walker J, Sutherland R, Khan S, Frymire E, Tu JV, Shah BR.

CMAJ. 2019 Nov 25;191(47):E1291-E1298. doi: 10.1503/cmaj.190899.

5.

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.

Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M, Frymire E, Khan S, Johnson AP; Bleeding Effected by Direct Oral Anticoagulants (BLED-AC) Study Group.

Thromb Res. 2019 Oct;182:12-19. doi: 10.1016/j.thromres.2019.07.026. Epub 2019 Aug 2.

PMID:
31434018
6.

Do Incentive Payments Reward The Wrong Providers? A Study Of Primary Care Reform In Ontario, Canada.

Glazier RH, Green ME, Frymire E, Kopp A, Hogg W, Premji K, Kiran T.

Health Aff (Millwood). 2019 Apr;38(4):624-632. doi: 10.1377/hlthaff.2018.05272.

PMID:
30933575
7.

Physician attendance during interhospital patient transfer in Ontario: 2005-2015.

Wonnacott D, Frymire E, Khan S, Green ME.

Can J Rural Med. 2019 Apr-Jun;24(2):37-43. doi: 10.4103/CJRM.CJRM_22_18.

8.

Emergency Department Use and Enrollment in a Medical Home Providing After-Hours Care.

Kiran T, Moineddin R, Kopp A, Frymire E, Glazier RH.

Ann Fam Med. 2018 Sep;16(5):419-427. doi: 10.1370/afm.2291.

9.

Hospital admission rates and emergency department use in relation to glycated hemoglobin in people with diabetes mellitus: a linkage study using electronic medical record and administrative data in Ontario.

Birtwhistle R, Green ME, Frymire E, Dahrouge S, Whitehead M, Khan S, Greiver M, Glazier RH.

CMAJ Open. 2017 Jul 11;5(3):E557-E564. doi: 10.9778/cmajo.20170017.

10.

Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.

Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M, Khuu W, Frymire E, Johnson AP; Bleeding Effected by Direct Oral Anticoagulants (BLED-AC) Study Group.

Chest. 2017 Jul;152(1):81-91. doi: 10.1016/j.chest.2017.02.009. Epub 2017 Feb 17.

11.

Medication Knowledge Among Older Adults Admitted to Home Care in Ontario During 2012-2013.

Sears K, Woo KY, Almost J, Wilson R, Frymire E, Whitehead M, VanDenKerkhof E.

J Healthc Qual. 2018 May/Jun;40(3):e33-e45. doi: 10.1097/JHQ.0000000000000055.

PMID:
27579602
12.

Intermittent androgen suppression for rising PSA level after radiotherapy.

Crook JM, O'Callaghan CJ, Duncan G, Dearnaley DP, Higano CS, Horwitz EM, Frymire E, Malone S, Chin J, Nabid A, Warde P, Corbett T, Angyalfi S, Goldenberg SL, Gospodarowicz MK, Saad F, Logue JP, Hall E, Schellhammer PF, Ding K, Klotz L.

N Engl J Med. 2012 Sep 6;367(10):895-903. doi: 10.1056/NEJMoa1201546. Erratum in: N Engl J Med. 2012 Dec 6;367(23):2262.

13.

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.

Goss GD, Arnold A, Shepherd FA, Dediu M, Ciuleanu TE, Fenton D, Zukin M, Walde D, Laberge F, Vincent MD, Ellis PM, Laurie SA, Ding K, Frymire E, Gauthier I, Leighl NB, Ho C, Noble J, Lee CW, Seymour L.

J Clin Oncol. 2010 Jan 1;28(1):49-55. doi: 10.1200/JCO.2009.22.9427. Epub 2009 Nov 16.

PMID:
19917841

Supplemental Content

Loading ...
Support Center